daewoong ipf cs pharma british

Bio & Pharma Samsung Biologics bags $514 mn CMO contract from US pharma

Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO), said on Monday it has secured a $5.14 million order from...

Business & Politics Wycombe Abbey to establish 1st Korean campus in Incheon’s Midan City

Wycombe Abbey, one of the UK’s leading independent boarding schools, has been chosen as the top bidder to establish an international school in...

Bio & Pharma Samsung Biologics signs $1.4 bn CMO deal with European pharma

South Korea's Samsung Biologics Co., the world’s largest contract drugmaker, said on Tuesday it signed a $1.4 billion contract manufacturing o...

Bio & Pharma Boryung, Lotus Pharma signs CDMO deal on anticancer injection

South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...

Bio & Pharma Hanmi Pharma to move up launch of anti-obesity drug

South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...

Bio & Pharma Samsung Biologics wins $668 million CDMO deal with European pharma

Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...

Bio & Pharma Korea’s Lunit in AI-powered lung cancer diagnostics deal with AstraZeneca

Lunit Inc., a South Korean AI-powered cancer diagnostics company, has partnered with global biopharma giant AstraZeneca plc. to jointly enter the AI...

Bio & Pharma IMBiologics transfers autoimmune disease drug tech to Huadong Pharma

South Korea's antibody-based biotech company IMBiologics announced on Friday that it signed a contract to transfer the technology of its autoimmune ...

Bio & Pharma Daewoong wins permission for Nabota in Argentina

South Korea's Daewoong Pharmaceutical Co. announced on Monday that its botulinum toxin Nabota received product approval from Argentina's National Ad...

Automobiles GM Korea supplier Erae cs eyes revival by unit sales

A controlling stake in Erae AMS Co., formerly Delphi Automotive Systems’ South Korean affiliate, is on sale with eight potential bidders eyein...

Bio & Pharma Kwangdong Pharma acquires stake in Precision Bio

South Korea's Kwangdong Pharmaceutical announced on Tuesday that it signed a stock purchase agreement to acquire Precision Biosensor Inc., a company...

Bio & Pharma Daewoong, Indonesia's IPB to co-research on primate

South Korea's Daewoong Pharmaceutical Co. announced on Thursday that it signed a contract with Indonesia's Bogor Agricultural University (Institut P...

Bio & Pharma Samsung Biologics eyes windfall gain amid US-China row

SAN DIEGO – Samsung Biologics Co. is enjoying a stream of contract development and manufacturing order inquiries from big pharmaceutical compa...

Bio & Pharma HK inno.N to release K-CAB in MENA market

South Korean bio-health company HK inno.N announced on Tuesday that it signed a contract with Saudi Arabian local pharmaceutical company Tabuk Pharm...

Mergers & Acquisitions Hanmi’s planned merger with OCI scrapped as sons win family feud

Hanmi Pharmaceutical Group’s proposed merger with OCI Holdings Co. has collapsed after two sons of the group’s founding family, who oppo...

Logistics Samsung SDS gets CEIV Pharma certification

South Korea's Samsung SDS Co. said on Wednesday that it has achieved the Center of Excellence for Independent Validators in Pharmaceutical Logistics...

Bio & Pharma Daewoong Pharmaceutical digitizes DB of 800 mn chemical compounds

South Korea's Daewoong Pharmaceutical announced on Monday that it has established a drug development system Daewoong AI System (DAISY) which combine...

Bio & Pharma Daewoong gets stem cell facility license in Indonesia

South Korea's Daewoong Pharmaceutical announced on Tuesday that its subsidiary Daewoong Biologics Indonesia has obtained a stem cell Lab Operational...

Bio & Pharma JW Pharma takes gout drug Epaminurad to Malaysia for phase 3

South Korea's JW Pharmaceutical Corp., announced on Monday that it has received approval from the Malaysian National Pharmaceutical Regulatory Age...

Bio & Pharma Daewoong exports $92.4 mn Depot injection tech to UAE

South Korea's Daewoong Pharmaceutical announced on Monday that it exported its technology for clinical development and commercialization rights of i...

Bio & Pharma Daewoong Pharm set to export Envlo Tab to Russia, CIS

Daewoong Pharmaceutical, a leading South Korean pharmaceutical company will export its new diabetes drug Envlo Tab. (active ingredient:enavogliflozi...

Business & Politics S.Korea-UK upgrade bilateral ties, sign deals on nuclear plants, chips

LONDON – South Korea and the UK have agreed to upgrade their bilateral relationship and closely cooperate in the defense, security and busines...

Korean games Faker’s T1 wins League of Legends global championship

South Korea’s video game team T1 led by local hero and professional player Lee “Faker” Sang-hyeok won the 2023 League of Legends W...

Leadership & Management Hyundai’s Chung: 1st Korean awarded top UK Order from King Charles

Hyundai Motor Group Chairman Chung Euisun has been named a Commander of the Order of the British Empire (CBE) for promoting economic and cultural co...

Bio & Pharma South Korean bio, pharma industry set to take leap

South Korea’s chemical maker LG Chem Ltd. is expected to reap more than 1 trillion won ($768.5 million) in sales this year from its new growth...

Bio & Pharma Daewoong Pharma, Merck team up for AI tech for new drug

South Korea's Daewoong Pharmaceutical announced on Tuesday it signed with memorandum of understanding (MOU) with Merck Life Science to build an arti...

Energy CS Wind eyes $2.2 bn sales in 2024 with Bladt

CS Wind Corp., a South Korean wind turbine tower manufacturer, expects its sales next year to double from last year’s to reach about 3 trillio...

Bio & Pharma Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved

South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...

Bio & Pharma Daewoong Pharma's GER drug gets product OK from Mexico

South Korea’s Daewoong Pharmaceutical on Wednesday said its gastroesophageal reflux (GER) disease drug Fexuclue (active ingredient fexuprazan ...

Bio & Pharma Humedix gets gov't OK for trials of dementia candidate drug

South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...